[{"Assets_0_Q3_USD":"12058462000.0","CIK":"12208","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-5.52","EarningsPerShareBasic_3_Q3_USD":"-149.6","EarningsPerShareDiluted_1_Q3_USD":"-5.52","EarningsPerShareDiluted_3_Q3_USD":"-149.6","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","Market Cap":"16656203893.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"104027000.0","NetIncomeLoss_1_Q3_USD":"-164232000.0","NetIncomeLoss_3_Q3_USD":"-4461029000.0","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","RevenuesConverted_1_Q3_USD":"680800000.0","RevenuesConverted_3_Q3_USD":"2071961000.0","SP500":"SP500","Sector":"Capital Goods","StockholdersEquity_0_Q3_USD":"8453605000.0","Ticker":"BIO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"29733000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"29819000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"29733000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"29819000.0","filed":"20221028","footnote":null,"form":"10-Q","fp":"Q3","fy":"2022.0","name":"BIO-RAD LABORATORIES, INC.","period":"20220930","qtrs":"0","uom":"USD"}]